Generation Bio Co bullishGeneration Bio Co. operates as a biotechnology company. The Company engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases.
−1.97USD
−126.61 MUSD
5.90 MUSD
48.54 M
About Generation Bio Co.
Sector
CEO
Cameron Geoffrey McDonough
Headquarters
Cambridge
Website
Employees (FY)
174
Founded
2016
ISIN
US37148K1007
FIGI
BBG00K698K88
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
$GBIO - important level to break$35-35.5 - breaking this level opens the road to target 1: $43
Target 2: 48 is potential if trend is broken
GBIO Bouncing Off High-Volume AreaGeneration Bio stock is triggering long on both a technical and fundamental bases. Two company insiders (board members) bought the stock in their personal accounts for a total investment of $599,000.
Additionally, GBIO is bouncing off it's high-volume areas where buyers have a history of stepping in
GBIOSHORT-TERM: Local divergence on the 4hr and potential hidden bullish divergence on the daily, over a critical support, entry has to be tactical though. (Stock market is volatile right now and not financial advice)
GBIO is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Generation Bio is an innovative genetic medicine company creating a new class of gene therapy.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GBIO is 2.80 USD — it has increased by 0.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Generation Bio Co. stocks are traded under the ticker GBIO.
Generation Bio Co. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
GBIO stock is 5.19% volatile and has beta coefficient of 3.95. Check out the list of the most volatile stocks — is Generation Bio Co. there?
One year price forecast for Generation Bio Co. has a max estimate of 10.00 USD and a min estimate of 5.00 USD.
GBIO earnings for the last quarter are −0.43 USD per share, whereas the estimation was −0.50 USD resulting in a 13.13% surprise. The estimated earnings for the next quarter are −0.46 USD per share. See more details about Generation Bio Co. earnings.
Generation Bio Co. revenue for the last quarter amounts to 2.15 M USD despite the estimated figure of 1.09 M USD. In the next quarter revenue is expected to reach 1.26 M USD.
Yes, you can track Generation Bio Co. financials in yearly and quarterly reports right on TradingView.
GBIO stock has fallen by 29.29% compared to the previous week, the month change is a 6.04% fall, over the last year Generation Bio Co. has showed a 37.36% decrease.
GBIO net income for the last quarter is −35.19 M USD, while the quarter before that showed −28.27 M USD of net income which accounts for −24.48% change. Track more Generation Bio Co. financial stats to get the full picture.
Today Generation Bio Co. has the market capitalization of 184.81 M, it has increased by 5.84% over the last week.
No, GBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Generation Bio Co. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 174.00 employees. See our rating of the largest employees — is Generation Bio Co. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Generation Bio Co. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Generation Bio Co. stock shows the sell signal. See more of Generation Bio Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Generation Bio Co. future price: according to them, GBIO price has a max estimate of 10.00 USD and a min estimate of 5.00 USD. Read a more detailed Generation Bio Co. forecast: see what analysts think of Generation Bio Co. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Generation Bio Co. EBITDA is −126.28 M USD, and current EBITDA margin is −2.14 K%. See more stats in Generation Bio Co. financial statements.